Select Bibliography

Filter by any of these (after searching):

J Gastrointest Cancer

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 4 items

Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943.

Alberts, Steven R , Sande, Jonathan R , Foster, Nathan R ... - - J Gastrointest Cancer - 2007

Manuscript - Primary - Primary - GI - NCCTG-N9943

Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.

Alberts, Steven R , Suman, Vera J , Pitot, Henry C ... - - J Gastrointest Cancer - 2007

Manuscript - Primary - Primary - GI - NCCTG-964251

Socioeconomic disparities in gastric cancer and identification of a single SES variable for predicting risk

Sarkar, Srawani , Dauer, Marc J. ... - - J Gastrointest Cancer - 2022

Manuscript - Primary - Primary - Disparities - Pilot

Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: a Report from Three Prospective Alliance Clinical Trials.

Smith, Ron S , Foster, Nathan R , Jatoi, Aminah , Thomé, Stephan D ... - - J Gastrointest Cancer - 2022

Manuscript - Primary - Meta-Analysis - GI - A151402 , N0044 , N044E , N0342